Validation Summary Report (VSR)

Equipment: Slitting Machine

Subcategory: Transdermal Patches (TDS)

Area: Production

Summary

This Validation Summary Report outlines the validation activities conducted for the Slitting Machine used in the production of Transdermal Patches. The validation process includes Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ), all of which have been executed successfully.

Scope/Boundaries

The scope of this validation includes the assessment of the Slitting Machine’s capabilities, focusing on the critical parameters identified in the User Requirement Specification (URS) Annex 11. This report covers the validation activities performed within the production area, specifically for the manufacturing of transdermal patches.

Executed Protocol List

DQ Protocol
IQ Protocol
OQ Protocol
PQ Protocol

Deviations Summary

No significant deviations were noted during the validation process. All protocols were executed as planned, adhering to the acceptance criteria outlined in the URS Annex 11.

CPP Verification Summary

The following key critical parameters were verified:

Slitting width
Blade alignment
PLC logs

All critical parameters met the acceptance criteria as specified in the URS Annex 11.

Conclusion

The Slitting Machine has successfully passed all validation phases (DQ, IQ, OQ, PQ) with no deviations. The equipment is deemed qualified for use in the production of Transdermal Patches, with a requalification frequency of 12 months.

Attachments Index

Attachment 1: DQ Protocol Document
Attachment 2: IQ Protocol Document
Attachment 3: OQ Protocol Document
Attachment 4: PQ Protocol Document

Approvals

_____________________
Validator Name
Date

_____________________
Quality Assurance Name
Date